The Overlooked Valve: Why Women With Aortic Stenosis Fall Through the Cracks
Pam R. Taub, MD, FACC, FASPC
Quantifying CKD-aP: Tools for Better Care
James Burton, DM, FRCP
Emilio Sanchez, MD, PhD
Decoding Itch in CKD: From CKD-aP Suspicion to Solution
Leonie Kraft, MD
Lucio Manenti, MD, PhD
CKD-aP Treatment Tool Kit
CKD-aP or Something Else? Decoding the Diagnosis
The Patient-Clinician Connection in Managing CKD-aP
Beyond GDMT: Timely Consideration of Barostim in Heart Failure
Patrick J. McCann, MD
Rajeev Mohan, MD
Optimizing RAASi/MRA Therapy in Patients with Heart Failure, CKD, and Hyperkalemia: A Microlearning Curriculum Approach
Javed Butler, MD
Ellie Kelepouris, MD, FACP, FAHA
Patrick Rossignol, MD, PhD
Emerging Therapies in Managing Adult and Pediatric Patients With FSGS: Latest Data
Vladimir Tesar
Meghan Sise, MD
Treatment Considerations for Pediatric Patients With FSGS
Kenneth Lieberman, MD
Monitoring FSGS: Traditional and Novel Biomarkers
The Clinical Weight of TTR: What the Latest Data Reveal
Ahmad Masri, MD, MS
Rola Khedraki, MD, FACC
Optimizing IgAN Care: Achieving Lower Proteinuria Targets With Combination Therapy
Jonathan Barratt, MD, PhD
Sydney Tang, MBBS, MD
Continuity in Care: Strategies for Managing Growth Hormone Deficiency Through Life’s Stages
Aristides Maniatis, MD
Kari Hosack
Meagan Broeckert
Sam Watson
Optimizing VNS Parameters: Keys to Therapeutic Success
Raman Sankar, MD, PhD
Scott Aaronson, MD
Differentiating Neuromodulation Therapies: VNS, DBS, ECT, TMS